BioVendor Research and Diagnostic Products is one of the leading manufacturers of antibodies, recombinat proteins and immunoassays.
The primary focus of the BioVendor R&D news, 03 / 2008, is on novel proteins discovered to be involved in the regulation of metabolic processes in lipoprotein metabolism, diabetes, metabolic syndrome and energy metabolism from various points of view.
The aim of the study was to determine whether serum levels of hyperphosphorylated neurofilament NF-H correlate with severity of brain injury in children.
The diagnostics of central nervous system diseases is often difficult (particularly for first-line physicians – cerebrovascular accidents, Alzheimer disease, central nervous system traumas etc.). It…
FGF-21 is novel metabolic regulator produced primarily by the liver. FGF-21 is a potent activator of glucose uptake on adipocytes, protects animals from diet-induced obesity when overexpressed in transgenic…
Apolipoprotein D (apoD) is a 29-kDa 169-amino acid glycoprotein that is primarily associated with high density lipoproteins in human plasma. A fraction of human apoD, like other cysteine-containing apolipoproteins,…
FGF-21 is novel metabolic regulator produced primarily by the liver. FGF-21 is a potent activator of glucose uptake on adipocytes, protects animals from diet-induced obesity when overexpressed in transgenic…
Periostin was originally isolated as an osteoblast-specific disulfide linked 90 kDa secreted factor that shares a structural homology to the axon guidance protein fasciclin I and that functions as a…
BioVendor Laboratory Medicine, Inc.
Karasek 1767/1
621 00 Brno
Czech Republic
Phone: +420–549 124 185
Fax: +420–549 211 460
E-mail: info@biovendor.com
www.biovendor.com